Systemic sclerosis-associated interstitial lung disease von Perelas, Apostolos, Silver, Richard M, Arrossi, Andrea V, Highland, Kristin B

Volltext

Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? von Silver, Richard T.

Volltext

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis von Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael, Miller, Carole, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Koumenis, Iphigenia L, Sun, William, Sandor, Victor, Kantarjian, Hagop M

Volltext

Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values von Silver, Richard T, Krichevsky, Spencer

Volltext

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet von Barbui, Tiziano, Tefferi, Ayalew, Vannucchi, Alessandro M., Passamonti, Francesco, Silver, Richard T., Hoffman, Ronald, Verstovsek, Srdan, Mesa, Ruben, Kiladjian, Jean-Jacques, Hehlmann, Rȕdiger, Reiter, Andreas, Cervantes, Francisco, Harrison, Claire, Mc Mullin, Mary Frances, Hasselbalch, Hans Carl, Koschmieder, Steffen, Marchetti, Monia, Bacigalupo, Andrea, Finazzi, Guido, Kroeger, Nicolaus, Griesshammer, Martin, Birgegard, Gunnar, Barosi, Giovanni

Volltext

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative von Hoogen, Frank, Khanna, Dinesh, Fransen, Jaap, Johnson, Sindhu R., Baron, Murray, Tyndall, Alan, Matucci‐Cerinic, Marco, Naden, Raymond P., Medsger, Thomas A., Carreira, Patricia E., Riemekasten, Gabriela, Clements, Philip J., Denton, Christopher P., Distler, Oliver, Allanore, Yannick, Furst, Daniel E., Gabrielli, Armando, Mayes, Maureen D., Laar, Jacob M., Seibold, James R., Czirjak, Laszlo, Steen, Virginia D., Inanc, Murat, Kowal‐Bielecka, Otylia, Müller‐Ladner, Ulf, Valentini, Gabriele, Veale, Douglas J., Vonk, Madelon C., Walker, Ulrich A., Chung, Lorinda, Collier, David H., Csuka, Mary Ellen, Fessler, Barri J., Guiducci, Serena, Herrick, Ariane, Hsu, Vivien M., Jimenez, Sergio, Kahaleh, Bashar, Merkel, Peter A., Sierakowski, Stanislav, Silver, Richard M., Simms, Robert W., Varga, John, Pope, Janet E.

Volltext

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet von Baccarani, Michele, Cortes, Jorge, Pane, Fabrizio, Niederwieser, Dietger, Saglio, Giuseppe, Apperley, Jane, Cervantes, Francisco, Deininger, Michael, Gratwohl, Alois, Guilhot, François, Hochhaus, Andreas, Horowitz, Mary, Hughes, Timothy, Kantarjian, Hagop, Larson, Richard, Radich, Jerald, Simonsson, Bengt, Silver, Richard T, Goldman, John, Hehlmann, Rudiger

Volltext

Long‐term effects of the treatment of polycythemia vera with recombinant interferon‐α von Silver, Richard T.

Volltext

Experimental realization of an extended Fermi-Hubbard model using a 2D lattice of dopant-based quantum dots von Wang, Xiqiao, Khatami, Ehsan, Fei, Fan, Wyrick, Jonathan, Namboodiri, Pradeep, Kashid, Ranjit, Rigosi, Albert F., Bryant, Garnett, Silver, Richard

Volltext

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet von BARBUI, Tiziano, BAROSI, Giovanni, KILADJIAN, Jean-Jacques, KRÖGER, Nicolaus, MESA, Ruben, MCMULLIN, Mary F, PARDANANI, Animesh, PASSAMONTI, Francesco, VANNUCCHI, Alessandro M, REITER, Andreas, SILVER, Richard T, VERSTOVSEK, Srdan, BIRGEGARD, Gunnar, TEFFERI, Ayalew, CERVANTES, Francisco, FINAZZI, Guido, GRIESSHAMMER, Martin, HARRISON, Claire, HASSELBALCH, Hans Carl, HEHLMANN, Rudiger, HOFFMAN, Ronald

Volltext

Paul Klee’s progressive dyspnea: A series of historical and clinical vignettes, part V von Silver, Richard M

Volltext

IQGAP1 Regulates Actin Polymerization and Contributes to Bleomycin-Induced Lung Fibrosis von Akter, Tanjina, Atanelishvili, Ilia, Silver, Richard M, Bogatkevich, Galina S

Volltext

Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival von Silver, Richard T., Erdos, Katie, Taylor, Elwood, Scandura, Joseph M., Abu-Zeinah, Ghaith

Volltext

Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis von Bogatkevich, Galina S., Atanelishvili, Ilia, Bogatkevich, Andrew M., Silver, Richard M.

Volltext

Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience von Wang, Dandan, Zhang, Huayong, Liang, Jun, Li, Xia, Feng, Xuebing, Wang, Hong, Hua, Bingzhu, Liu, Bujun, Lu, Liwei, Gilkeson, Gary S., Silver, Richard M., Chen, Wanjun, Shi, Songtao, Sun, Lingyun

Volltext

Recombinant interferon-α may retard progression of early primary myelofibrosis: a preliminary report von Silver, Richard T., Vandris, Katherine, Goldman, Joshua J.

Volltext

Normal life expectancy for polycythemia vera (PV) patients is possible von Abu-Zeinah, Ghaith, Silver, Richard T., Abu-Zeinah, Khalid, Scandura, Joseph M.

Volltext

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival von Abu-Zeinah, Ghaith, Krichevsky, Spencer, Cruz, Tatiana, Hoberman, Gabriela, Jaber, Diana, Savage, Niamh, Sosner, Claudia, Ritchie, Ellen K., Scandura, Joseph M., Silver, Richard T.

Volltext

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial von Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Sun, Kang, Kantarjian, Hagop

Volltext

Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure von Harrison, Claire N., Schaap, Nicolaas, Vannucchi, Alessandro M., Kiladjian, Jean‐Jacques, Jourdan, Eric, Silver, Richard T., Schouten, Harry C., Passamonti, Francesco, Zweegman, Sonja, Talpaz, Moshe, Verstovsek, Srdan, Rose, Shelonitda, Shen, Juan, Berry, Tymara, Brownstein, Carrie, Mesa, Ruben A.

Volltext